Agentic AI stocks experienced a collective rally, with Palantir surging 10%, UiPath rising 7%, and C3.ai gaining 5%, indicating strong market confidence in the sector.

An investment analysis compares NVIDIA and UiPath to determine which artificial intelligence stock presents a better buying opportunity in 2026.

An analysis compares UiPath and ServiceNow to determine which agentic AI stock is the better buy for investors. The comparison focuses on their potential in the rapidly growing field of artificial intelligence.

Daniel Dines, the Romanian billionaire founder of UiPath, admits to feeling anxiety about artificial intelligence and the uncertain future careers of upcoming generations.

An article provides an analysis on whether Symbotic Inc. (SYM) is a good stock to buy now.

UiPath (PATH) stock is down more than 28% year-to-date, prompting investors to consider whether to short or buy the shares.

UiPath's coding agents successfully completed an automation project for a major consumer electronics manufacturer in three hours, a task that would typically take four weeks. This achievement was announced by UiPath CEO and founder Daniel Dines.

UiPath shares saw an increase after the company reported strong first-quarter financial results and raised its outlook for the future, indicating positive investor sentiment.

Wall Street analysts are offering varied insights on several technology companies, with some expressing bullish sentiment on top picks like Okta and Block, while others are conflicted on names such as comScore and MongoDB. Additionally, analysts are bullish on leading consumer cyclical stocks including BRP and Booking Holdings.

MongoDB has surpassed its first-quarter estimates and subsequently raised its full-year outlook, driven by strong performance in its Atlas database service, joining other tech companies in issuing updated positive financial forecasts.

The earnings transcript for UiPath (PATH) for the first quarter of 2027 has been released, detailing the company's financial performance.

UiPath shares have slipped after the launch of its Korea Automation Cloud, which is testing regional enterprise demand.

An article provides an analysis of UiPath, Inc. (PATH) to determine if it represents a good stock investment opportunity at the current time.

The article examines UiPath's (PATH) intensified focus on integrating agentic AI into ERP systems and autonomous enterprise workflows, signaling a strategic expansion in its automation offerings.

UiPath (PATH) has announced the appointment of Raghu Malpani as its new Chief Product and Technology Officer, a key leadership change for the automation software company.

Raghu Malpani, the Chief Technology Officer at UiPath, has taken on an expanded role as the company's Chief Product and Technology Officer.

An analysis explores whether it is an opportune time to invest in UiPath stock, given its recent decline in value.

UiPath shares dropped on March 12 after the company's slower growth outlook overshadowed its first full-year profit.

UiPath has released highlights from its fourth-quarter earnings call, providing insights into the company's financial performance.

Seeking Alpha presents a preview of UiPath's financial performance expectations for the fourth quarter of 2026.

An analysis pits Nebius against UiPath, suggesting one of the two companies has the potential to generate significant wealth for investors.

Palantir Technologies saw its stock price surge by 16% following a strong performance in its second-quarter earnings report.

UiPath's stock experienced a 1% decline on July 21, even as the broader technology sector saw a rebound. This performance contrasts with the general market trend for tech stocks.

An analysis compares UiPath and Zebra Technologies to determine which offers a better investment opportunity as a robotics stock.

UiPath Inc. is reportedly enhancing corporate service delivery standards through its UiPath MaestroTM platform, contributing to advancements in automation.

Analysts are evaluating whether UiPath (PATH) is positioned for a recovery following its recent earnings report, assessing its market potential.

The Romanian subsidiary of the AI company UiPath reported higher revenues for 2025, but increased expenses led the Bucharest-based firm to a net loss, according to official data.

UiPath has presented investors with two bullish signals alongside one warning sign, prompting a mixed outlook for the automation software company.

Bank of America has reiterated its 'Underperform' rating for UiPath, Inc. (PATH) stock.

Analysts have presented mixed opinions on the investment prospects of several technology stocks, including Datadog (DDOG), Elastic (ESTC), and UiPath (PATH), reflecting uncertainty in their market performance.

UiPath's stock experienced a decline following the release of its first-quarter results, which were described as mixed. Analysts are now evaluating the company's potential for growth acceleration.

UiPath reported a non-GAAP EPS miss but revenue beat, while MongoDB and NetApp both exceeded analyst expectations for non-GAAP EPS and revenue in their latest quarterly financial results.

RBC Capital has reaffirmed its 'Sector Perform' rating for UiPath, Inc. (PATH).

UiPath (PATH) has launched new AI-powered connectors on Salesforce AgentExchange, designed to facilitate enterprise orchestration and enhance automation capabilities within multi-vendor AI…

Options traders are showing significant activity and interest in UiPath stock. This indicates a notable market sentiment surrounding the company's shares.

UiPath (PATH) has seen its price target cut by analysts, despite the company reporting strong Annual Recurring Revenue (ARR) growth.

Software stocks, including UiPath, are experiencing increased tension and declines, driven by a peak in short interest and growing fears of disruption from artificial intelligence.

Analysts have shared their insights on technology companies UiPath (PATH) and The Descartes Systems Group (DSGX), discussing their performance and future prospects.

UiPath's stock declined despite positive news, which some analysts suggest could represent a buying opportunity for investors.

UiPath's stock plunged following its Q4 results, despite Needham upgrading the company to a 'Buy' rating based on its new Annual Recurring Revenue (ARR).

UiPath has issued guidance indicating a slower full-year revenue growth than previously anticipated, impacting investor expectations.

UiPath is leveraging agentic AI to streamline and resolve inefficiencies in healthcare payment processes, aiming to tackle existing bottlenecks in the industry.

An investor-focused analysis compares the quarterly revenue trends of artificial intelligence companies Marvell Technology and UiPath, providing insights into their financial performance.

UiPath shares saw gains on July 17 following the announcement of a new partnership focused on artificial intelligence applications in the retail sector.

UiPath's stock saw gains today as its agentic automation strategy is put to the test with upcoming earnings, drawing market attention to its performance.

UiPath Inc. (PATH) has made an announcement regarding its 'Maestro Case,' though specific details are not provided in the headline.

UiPath, a leading enterprise automation software company, has successfully obtained the Dubai Security Standard Certification, enhancing its credibility in the region.

UiPath Inc. (PATH) has strengthened its automation suite platform by introducing new tools, aiming to improve its offerings in the automation market.

Financial analysts are evaluating the investment prospects of CrowdStrike and UiPath, with discussions focusing on whether their stocks are currently a buy. UiPath's revenue acceleration is a key factor in its assessment.

A specific fund divested $35 million worth of shares in UiPath, an automation software company. This move occurred even as UiPath reported a 17% increase in revenue.

Analysts have provided their perspectives on the financial health and future prospects of technology companies Okta (OKTA), UiPath (PATH), and Autodesk (ADSK).

Key highlights from UiPath's first quarter earnings call have been released, summarizing the company's financial results and business outlook.

UiPath and Deloitte have announced an expanded collaboration to integrate UiPath's Test Cloud into Deloitte's Ascend platform.

UiPath (PATH) saw its stock price jump by 6% in anticipation of its upcoming earnings report.

UiPath (PATH) stock is currently trading 25% below analyst targets, following a substantial 36% year-to-date decline in its value.

UiPath (PATH) has launched a new Purchase-to-Pay solution, further extending its agentic automation initiatives.

Several stocks, including NVIDIA, Tesla, Intuitive Surgical, Deere, and Rockwell Automation, saw price changes following specific comments and recommendations from financial personality Jim Cramer, while others like Symbotic, UiPath, Ambarella, and SoundHound AI reacted negatively to his caution or criticism.

An analysis evaluates whether UiPath, Inc. (PATH) is currently a good stock to buy, providing insights into its market performance and investment potential.

Analysts have provided their insights and opinions on technology companies UiPath (PATH) and The Descartes Systems Group (DSGX), offering perspectives on their market performance and outlook.

UiPath aims to achieve an annual recurring revenue (ARR) of $2 billion by fiscal year 2027, driven by the rapid adoption of artificial intelligence, and has updated its long-term margin goals.

UiPath reported a Non-GAAP EPS of $0.30, beating estimates by $0.05, and revenue of $481.11 million, surpassing expectations by $16.3 million, along with issuing strong guidance for the future.

UiPath, Inc (PATH) has introduced a suite of new artificial intelligence tools specifically designed to address the unique needs and challenges within the healthcare industry.